EyeGate Pharmaceuticals vs NRG Therapeutics
EyeGate Pharmaceuticals vs NRG Therapeutics, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: EyeGate Pharmaceuticals is on 32/100 and NRG Therapeutics on 42/100.
Where each one leads
EyeGate Pharmaceuticals
- agent readiness: 39/100 against 25/100
- domain rating: 34/100 against 27/100
NRG Therapeutics
- our overall score: 42/100 against 32/100
- funding raised: $58.6M against $45.5M
At a glance
| Measure | EyeGate Pharmaceuticals | NRG Therapeutics |
|---|---|---|
| What it is | Clinical-stage specialty pharmaceutical company developing therapeutics and drug delivery systems for ophthalmic diseases. | A biotechnology company developing small molecule drugs to treat neurodegenerative diseases by targeting mitochondrial dysfunction. |
| Category | Biotech, MedTech, HealthTech, Drug Discovery | Biotech, MedTech, Drug Discovery, Neurodegenerative Diseases |
| Sells toBusiness model | B2B | B2C | B2B2C | B2G | B2B |
| Offering | Software | hardware | services | marketplace | platform | Software |
| Founded | 2000 | Not published |
| Headquarters | Waltham, United States | Stevenage, United Kingdom |
| Status | Active | Active |
Size, funding and growth
| Measure | EyeGate Pharmaceuticals | NRG Therapeutics |
|---|---|---|
| Employees | Not published | 23 |
| Total funding | $45.5M | $58.6M |
| Latest round | Debt | Series B |
| LinkedIn followers | Not published | 4,252 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | EyeGate Pharmaceuticals | NRG Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 32/100 | 42/100 |
| Traction | 38/100 | 53/100 |
| Team | 30/100 | Not published |
| Search visibility | 5/100 | 24/100 |
| Quality | 35/100 | 50/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | F (25/100) |
| Domain ratingLink authority, 0-100 | 34/100 | 27/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | EyeGate Pharmaceuticals | NRG Therapeutics |
|---|---|---|
| Hosting | Not detected | Self Managed |
| CDN | Cloudflare | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Not detected | Bootstrap |
| Analytics | Google Analytics 4, Google Tag Manager | Google Analytics 4 |
EyeGate Pharmaceuticals vs NRG Therapeutics: common questions
Which is better, EyeGate Pharmaceuticals or NRG Therapeutics?
On our 0-100 score NRG Therapeutics rates higher (42/100 against 32/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do EyeGate Pharmaceuticals and NRG Therapeutics compare on the numbers?
EyeGate Pharmaceuticals leads on agent readiness (39/100 against 25/100), domain rating (34/100 against 27/100). NRG Therapeutics leads on our overall score (42/100 against 32/100), funding raised ($58.6M against $45.5M).
Read the full EyeGate Pharmaceuticals review and pricing or the NRG Therapeutics review and pricing. You can also browse other EyeGate Pharmaceuticals alternatives we track.